-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Benign prostatic hyperplasia (BPH) is one of the most common causes of lower urinary tract symptoms (LUTS) in men
.
Surgical treatment is usually the treatment of choice for patients with moderate/severe drug-refractory LUTS
.
Transurethral resection of the prostate (TURP) and open prostatectomy (OP) are the gold standards for the treatment of small/medium and large prostates.
Holmium laser enucleation of the prostate (HoLEP) is one of the most studied surgical techniques for benign prostatic hyperplasia (BPH), and its efficacy in relieving symptoms has been widely described
.
However, there is little evidence on predictors of symptom recurrence
.
Evaluated the long-term outcome, symptom recurrence rate, and predictors of patients receiving HoLEP.
The researchers analyzed data on patients with benign prostatic hyperplasia who received consecutive HoLEP treatment at two tertiary referral centers from 2012 to 2015
.
At 12 months, 24 months, and 60 months of follow-up, the functional results were evaluated by urine flow rate parameters and the International Prostate Symptom Score (IPSS) questionnaire
.
A total of 567 patients’ data are available for analysis
.
Before surgery, the median prostate volume of all patients was 80cc, the median PFR was 8ml/s, and the median PVR was 100cc
.
Multivariate logistic regression analysis of predictors of symptomatic patients 60 months after HolEP surgery
Multivariate logistic regression analysis of predictors of symptomatic patients 60 months after HolEP surgeryIn summary, no matter which technique is selected, HoLEP can alleviate symptoms lastingly
.
For patients with important symptoms or high PVR before surgery, the risk of recurrence of symptoms should be carefully considered
.
Original source:
Matteo Droghetti Angelo Porreca, Lorenzo Bianchi et al.
Long-term outcomes of Holmium laser enucleation of prostate and predictive model for symptom recurrence .
Long-term outcomes of Holmium laser enucleation of prostate and predictive model for symptom recurrence
Leave a message here